Unclaimed brand
ARCALYST® (rilonacept) injection, the first and only FDA approved therapy for recurrent pericarditis treatment in patients 12 years or older.
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#54768F
Smalt Blue
84, 118, 143
205, 26, 45
41, 17, 0, 44
#13426B
Chathams Blue
19, 66, 107
208, 70, 25
82, 38, 0, 58
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
ARCALYST® (rilonacept) is a significant innovation in the treatment of recurrent pericarditis, recognized as the first and only therapy approved by the FDA for patients aged 12 and older. Developed by Kiniksa Pharmaceuticals, ARCALYST serves as an interleukin-1 blocker that not only addresses recurrent pericarditis but also manages associated conditions such as Cryopyrin-Associated Periodic Syndromes (CAPS) and Deficiency of Interleukin (IL-1) Receptor Antagonist (DIRA).
The therapy is designed to reduce flares, provide symptom relief, and promote long-term prevention of recurrence, thereby enhancing the quality of life for individuals affected by these conditions. The brand offers comprehensive support through its Kiniksa OneConnect™ program, which includes starter kits, treatment support, and financial assistance for patients. With a commitment to patient advocacy and education, ARCALYST aims to empower users to take control of their health, ensuring they have access to vital resources and community support.
Brand industry
Health
Company type
Suggest company type
Year founded
Suggest founded year
Company size
Suggest company size
How do I download the ARCALYST logo?
The ARCALYST logo comes in one version: a logo. Download as transparent PNG.
What are ARCALYST's brand colors?
The ARCALYST color palette uses the hex codes #54768F, #13426B and #FFFFFF.
The ARCALYST name, logos and brand assets are trademarks of ARCALYST and its affiliates. Brandfetch isn't affiliated with or endorsed by ARCALYST. Their use is subject to ARCALYST's brand guidelines.
